Amneal Pharmaceuticals Inc
Healthcare · EUR · F
Price
€10.459
Cap
€4.21B
Earnings
—
30d Trend
-4.2%
34% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 60×Macro 0.99 (−1%)=59
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%
BRAIN47 HORIZON ANALYSIS
Moderate long-term case — not compelling enough for a multi-year commitment
BRAIN47'S ASSESSMENT
I rate Amneal Pharmaceuticals Inc at 59/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 75/100. I classify this as a growth position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+1.2%
3 MONTHS
-6.2%
12 MONTHS
+77.4%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Moderate long-term case — not compelling enough for a multi-year commitment. Momentum (75) and Quality (55) are the primary strengths. Historical volatility is moderate at 34%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.